Next, we turned our attention to the receptors of the incretin hormones GLP-1 and GIP (Extended Data Fig. 8a–d), with both GLP1R and GIPR being targets for type 2 diabetes mellitus and obesity therapeutics24. The gene discussed is GLP1R; the disease is type 2 diabetes mellitus.